A phase 2B randomized controlled multicenter open-label study of the efficacy and immune responsoe of GVAX pancreas vaccine with cyclophosphamide and CRS-207 compared to chemotherapy
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Aduro BioTech
Start Date
April 1, 2014
End Date
April 23, 2018
Administered By
Duke Cancer Institute
Awarded By
Aduro BioTech
Start Date
April 1, 2014
End Date
April 23, 2018